FIELD: medicine.
SUBSTANCE: invention relates to the field of medicine, namely oncology, and can be used to predict tumor invasion into the capsule in papillary thyroid cancer. The method involves conducting a study of tumor biological markers in the patient’s tissue. RNA is isolated from tumor tissue and the expression of 4E-BP1 is determined, data on the size of the tumor and data on metastatic lesion of regional lymph nodes are taken into account before histological examination and the probability of tumor germination into the thyroid capsule is calculated.
EFFECT: use of the invention makes it possible to predict an unfavorable prognosis of the disease, namely the risk of tumor recurrence after treatment, in the early stages after thyroidectomy, before histological verification of the diagnosis.
1 cl, 1 dwg, 6 tbl, 2 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR PREDICTING THE DEVELOPMENT OF TUMOR RECURRENCE IN PAPILLARY THYROID CANCER | 2022 |
|
RU2795086C1 |
METHOD FOR DIAGNOSING MALIGNANT NEOPLASMS OF THYROID GLAND | 2023 |
|
RU2820815C1 |
METHOD FOR PREOPERATIVE DIFFERENTIAL DIAGNOSIS OF BENIGN AND MALIGNANT THYROID TUMOURS | 2016 |
|
RU2614700C1 |
METHOD FOR COMPLEX PREOPERATIVE DIFFERENTIAL DIAGNOSIS OF BENIGN AND MALIGNANT NODULES OF THE THYROID GLAND | 2022 |
|
RU2805941C1 |
METHOD FOR PREDICTION OF OCCURRENCE OF LOCAL RECURRENCES IN POSTOPERATIVE PERIOD IN PATIENTS WITH LOCALLY ADVANCED BREAST CANCER | 2020 |
|
RU2734719C1 |
DIFFERENTIAL DIAGNOSTIC TECHNIQUE FOR INDIVIDUAL'S THYROID NEW GROWTHS | 2014 |
|
RU2569154C1 |
METHOD FOR PREOPERATIVE DETERMINATION OF EXTENT OF SURGERY FOR HIGH-DIFFERENTIATED THYROID CARCINOMA | 2014 |
|
RU2548783C1 |
METHOD FOR PREDICTION OF RISK OF DEVELOPING DISTANT METASTASES IN PATIENTS WITH OPERABLE FORMS OF BREAST CANCER WITH METASTASES IN REGIONAL LYMPH NODES | 2020 |
|
RU2733697C1 |
METHOD FOR ASSESSING THE RISK OF THYROID CANCER IN A PATIENT WITH NODULAR THYROID FORMATIONS | 2019 |
|
RU2725749C1 |
METHOD OF PREDICTING HIGH RISK OF REGIONAL METASTASIS IN BREAST CANCER | 2023 |
|
RU2816441C1 |
Authors
Dates
2022-10-04—Published
2022-01-19—Filed